Subscribe to our Newsletters !!

    USP

    Lupin, Concord Biotech get USFDA gesture for generic immunosuppressant cases

    New Delhi, Nov 12 (PTI) Drug firm Lupin on Thursday stated that in alliance with Concord Biotech, it has obtained acceptance from the US health regulator to market generic immunosuppressant Tacrolimus capsules used in the Western industry. In cooperation with Concord Biotech, the business has obtained approval from the United States Food and Drug Administration